Dipna Pharmachem Ltd — Board Meeting, 26-11-2025: Board Meeting

Dipna Pharmachem's board approved Q2/H1 financial results. Income from operations was Rs 73.54 Cr, with a net profit of Rs 1.41 Cr for the half-year. Funds raised from Rights Issue (~Rs 11.84 Cr) and Preferential Warrants (~Rs 18.93 Cr) saw no deviation in utilization.